Drug Trial Radar · NCT00151437
Canadian Pegvisomant Compassionate Study In Acromegalic Patients
Last checked: Nov 20, 2026Latest source record: Apr 24, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Nov 2004
Primary completion
Not stated
Study completion Apr 2007
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Sep 9, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purposes of this study are: 1) to provide SOMAVERT for compassionate use to patients with acromegaly or who have completed clinical trials and were responsive, and 2) to evaluate the safety and tolerability of SOMAVERT.
Conditions
- Acromegaly
Interventions
Pegvisomant treatmentDrug
Medical History, demographicsProcedure
Sign and symptoms: questionnaireProcedure
Blood tests: IGF-1, AST/ALT/ALP/TBIL, GTTProcedure
MRIProcedure
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patient's IGF-1 levels normalize signs and symptoms of acromegaly normalize
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Pfizer Investigational Site
Edmonton, Alberta, Canada
Pfizer Investigational Site
Edmonton, Alberta, Canada
Pfizer Investigational Site
Halifax, Nova Scotia, Canada
Pfizer Investigational Site
Toronto, Ontario, Canada
Pfizer Investigational Site
Montreal, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.